Sreeja Biswas

Premium

General

03 September, 2024

Grapevine: Mankind plans fundraise for BSV deal; Raymond to list two more units

Mankind Pharma Ltd plans to raise over Rs 9,000 crore ($1.2 billion) through non-convertible debentures (NCDs) and short-term commercial paper to ......

Premium

Healthcare

02 September, 2024

Exclusive: PE-backed platforms in fray for API maker Aurore Life

Hyderabad-based bulk-drugs maker Aurore Life Sciences has attracted interest from a number of suitors, including pharmaceutical platforms formed by private ......

Premium

Healthcare

02 September, 2024

Searchlight: Hetero Health rebounds after post-COVID crash on manufacturing boost

Hetero Healthcare Ltd, which is a part of one of the major pharmaceutical groups in India Hetero group, witnessed a ......

Premium

General

02 September, 2024

Grapevine: Coca-Cola gets suitors for India arm; Infra.Market picks banks for IPO

The Burman family of Dabur and the Bhartias, promoters of Jubilant Group, are nearing a deal to acquire a 40% ......

Premium

Healthcare

30 August, 2024

Former Practo, Unacademy exec foraying into elder care with new venture

Vikas Kumar, a founding team member at digital healthcare platform Practo and former chief business officer at edtech unicorn Unacademy, ......

Premium

General

29 August, 2024

Grapevine: MUFG to step up India play; Quadria to finish Fund I exit by year-end

MUFG Bank aims to accelerate its investments in India, where it has over $10 billion (Rs 83,898 crore) in exposure, including ......

Healthcare

28 August, 2024

PE-backed Medikabazaar names former Healthium Medtech exec new CEO

Medikabazaar, a business-to-business online marketplace for medical supplies, said Wednesday it has appointed Dinesh Lodha as the new group CEO.  Lodha, ......

Premium

General

28 August, 2024

Grapevine: Fairfax, Bain eye API maker; ChrysCap nears deal for Belgian Waffle

Canadian billionaire Prem Watsa's Fairfax and US private equity firm Bain Capital are competing to acquire Vadodara-based API maker Farmson Basic Drugs in a deal ......

Premium

Healthcare

27 August, 2024

Temasek-backed firm, Zydus may recast API, gelatine business of Sterling Biotech

The owners of Sterling Biotech--Generic drugmaker Zydus Lifesciences Ltd and private equity Temasek-backed Perfect Day Inc—plan to restructure some of the businesses ......

Premium

Finance

27 August, 2024

Fairfax sells stake in health insurance third party aggregator arm

Fairfax Asia, part of the bigger financial services conglomerate Fairfax Financial Holdings Ltd owned by billionaire Prem Watsa, has sold ......